JWCAR201 for the Treatment of Hematology Malignancy and Autoimmune Diseases

Clinical trial NCT06567080 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06567080
Sponsor: RenJi Hospital
Status: NOT_YET_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

B-cell Tumors Autoimmune Diseases Lupus Erythematosus, Systemic Large B-cell Lymphoma

Start date: 2024-09-01
Primary completion: 2025-09-01
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.